What you'll learn
With the growing threat of COVID-19 hitting the world, the enthusiasm of gaining awareness on this pandemic has become routine among the normal individual. The COVID-19 pandemic has sparked an unprecedented wave of research, data sharing and open science as the scientific world seeks to understand the disease, track its spread and analyze the SARS-CoV-2 virus that causes COVID-19. The WHO estimates an average mortality rate of 3.4%, which is around 100 times higher than flu — but do note that average is across age brackets. Current evidence suggests that the fatality rate from Covid-19 ranges from 9% to 19% for older individuals, as well as for people with conditions such as cardiovascular disease, diabetes, and cancer and those who are immunocompromised. Even if you are not at high risk yourself, we still all have a public health obligation to take interventions that will prevent spread and overwhelm the health care system.This can only be possible if we have a thorough and exhaustive knowledge on COVID 19 which can help us to implement it in our day to day life. As COVID is a respiratory infection and can spread from animals to humans and humans to humans, it has progressively become a pandemic in a short period which awakens us to build up knowledge to how to break the chain of COVID 19.
At present, in hospital admissions, around 20–51% of patients reported as having at least one comorbidity, with diabetes (10–20%), hypertension (10–15%) and other cardiovascular and cerebrovascular diseases (7–40%) being most common among others. These have high impact on the COVID patients leading to severe complications and early mortality.
This course essentially deals with co morbidities such as cancer, diabetes, ARDS, pregancy, cardiac diseases etc in COVID -19 patients which is worth learning.
Key concepts covered include:
- Cancer Care during COVID-19 Pandemic
- Diabetes and COVID-19
- ARDS in Novel Corona
- Risk of COVID-19 in Cardiac Patients
- COVID-19: Issues concerning Pregnancy
Dr. Ayesha is a Consultant of Medical Affairs at Medvarsity. Her research interest is in Infectious diseases. She has published many original peer-reviewed articles in major medical journals. These papers address important clinical questions related to the epidemiology, risk factors, clinical presentation, diagnosis, management, complications, outcomes, and cost associated with various infectious diseases.5th line is the diagnosis, management, complications, outcomes, and cost associated with various infectious diseases.
Medvarsity short description is the pioneer in online medical education and is now Asia’s largest company in the domain with more than 50,000 graduates who have upskilled through the courses offered by the organization and more than 10,000 active learners who are engaged in their online medical courses and contact programs.